Is this big investing mistake costing you a fortune?

Keep your investing simple and under your control by buying quality stocks like Insurance Australia Group Limited (ASX:IAG) and Resmed Inc. (CHESS) (ASX:RMD).

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the biggest investing mistakes is using leverage to buy shares.

Margin lending allows you to borrow money from a broker to buy stocks. You put up a little of your money and they put up the rest, something akin to a home loan. If a stock goes up, your earnings are proportionally bigger, but so are your losses when the stock goes south.

If you lose too much, the broker will request that you either put in more money, or sell down the stock to cover the difference. Apart from potentially losing your money fast, the power to decide when to sell is out of your control.

By using only your own cash, you could hold the stock for a hundred years and never have to sell if you didn't want to. Also, you can wait out weak periods when share prices fall.

Should a stock fall 20% – 30%, you could resist the urge to sell out of fear, saving your position. Not so with margin loans. You'd be sold out and left with a loss.

Keep your investing simple and under your control. Here are two quality companies that you could start making your fortune with.

— Insurance Australia Group Limited (ASX: IAG)

The market leader in general insurance has been raising dividends over the past five years. It offers a great 5.8% fully franked dividend. The general insurance business is improving recently with fewer big natural disaster claims and the stock hit a new multi-year high at the end of July.

Resmed Inc. (CHESS) (ASX: RMD)

This healthcare company develops breathing aids and respiratory devices. Such equipment is in constant demand and the rise in both revenue and earnings every year for the past four years shows it. The majority of its business is from overseas in big healthcare markets like the US and Europe.

Its dividend yield is 2.1% unfranked and analyst consensus forecasts have earnings rising over an average 10% annually for the next two years.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »